NLRP3 and pulmonary fibrosis: MCC950 has shown its protective property through inhibition of NLRP3 activation in silicon dioxide-induced pulmonary fibrosis through preventing macrophage-derived IL-1β excretion and then impeding myofibroblasts transition [111].